Browse News
Filter News
Found 518,518 articles
-
Politicians might deny climate change, but disease-carrying insects and their pathogens aren’t—they’re exploiting it.
-
Medtech Infraredx Anticipates Trial Data Will Support ‘Holy Grail’ of Cardiovascular Imaging Tool
9/26/2018
A new cardiovascular imaging tool could prevent the possibility of people experiencing a second or third heart attack. -
Going out of your way to overly ingratiate yourself with your boss (aka “kissing up”) may not be the most ‘attractive’ quality to display in the workplace, but there’s no denying that being proactive about getting your boss on your side can have some positive results … for the short term, anyway.
-
Evolve Biologics™ Provides Update on Progress in Phase III Trial for PlasmaCap™ IG (Intravenous Immunoglobulin)
9/26/2018
More than 80% of Required Infusions Now Successfully Administered in Adult Portion of Study
-
Agilent to Expand Portfolio and Capabilities in Cell Analysis with Acquisition of ACEA Biosciences
9/26/2018
Acquisition adds a differentiated portfolio and organizational capabilities in the fast-growing cell analysis market
-
AVITA Medical Announces Receipt of $1 Million Research and Development Tax Credit
9/26/2018
AVITA Medical announced that it has received a Research and Development Tax Incentive cash rebate from the Australian Tax Office in the amount of A$1.0 million for the year ending 30 June 2017.
-
Maintenance of motion at L5/S1 does matter.
9/26/2018
NASS 2018 oral podium presentations answer common questions about long-term clinical value of lumbar motion preservation
-
PeptiDream Announces Drug Discovery and Development Agreement with Santen Pharmaceutical
9/26/2018
PeptiDream Inc. announced today that it has entered into a broad-based multi-target discovery and development agreement with Osaka-based Santen Pharmaceuticals Co., Ltd., (“Santen”).
-
AstraZeneca and its MedImmune division released data on overall survival (OS) in its Phase III PACIFIC clinical trial of Imfinzi (durvalumab).
-
Swiss pharmaceutical giant Novartis plans to slash approximately 2,200 jobs in Switzerland over the next four years.
-
This morning, Genentech released results of its Phase III IMpower 133 trial that showed treatment with Tecentriq plus chemotherapy helped people with extensive-stage small cell lung cancer live significantly longer than with chemotherapy alone.
-
Verastem Gets FDA Approval for Leukemia Drug, Will Make It Immediately Available to Patients
9/25/2018
Shares of Verastem closed out Monday trading on a positive note and continues to climb in the premarket following the greenlight for leukemia drug Copiktra, an inhibitor of phosphoinositide 3-kinase (PI3K)-delta and PI3K-gamma. -
A commercially-available medical device developed by Medtronic is helping paralyzed patients walk again.The device, which stimulates the spinal cord through electrical pulses, has been successful in helping some individuals who lost the ability to walk through injuries to their spine, regain the ...
-
Tesaro Highlights Benefits of Maintenance Therapy Zejula During Ovarian Cancer Awareness Month
9/25/2018
Ovarian cancer is the fifth leading cause of cancer-related deaths in the United States. It is estimated that this year there will be more than 22,000 women in the U.S. diagnosed with the disease and about 14,000 disease-related deaths. -
Biotechnology company Morphic Therapeutic has just publicized their completion of a successful $80 million Series B financing meant to support their two lead programs in developing modern oral integrin therapies, as well as further other clinic programs.
-
Pharma Companies React to Employers and Health Plans Excluding New Therapies Based on Cost
9/25/2018
Recently, a few companies and government programs have decided to enact their own plans that they believe will help bring down the cost of new therapies. Pharmaceutical companies have begun asserting their positions on the topic. -
As the acquisition of Dublin-based Shire by Japan-based Takeda Pharmaceutical edges forward, yet another major Takeda shareholder has spoken out in opposition to the deal.
-
Are you ready to look for a new job? If you have made the decision to put yourself on the job market, there are a few things that you need to do right away to get yourself ready for the process… and it is a process.
-
KalVista Pharmaceuticals to Present at 2018 Cantor Global Healthcare Conference
9/25/2018
KalVista Pharmaceuticals, Inc. today announced that it will present at the Cantor Global Healthcare Conference on Tuesday, October 2, 2018, at 8:00 a.m. ET in New York, NY.
-
Akebia Therapeutics to Participate in Upcoming October 2018 Investor Conferences
9/25/2018
Akebia Therapeutics, Inc. today announced that it will participate in the following investor conferences: